JIANJUN GAO to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications JIANJUN GAO has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.039
-
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials. Clin Genitourin Cancer. 2022 02; 20(1):e16-e24.
Score: 0.039